TGFB1 and neoplasm: This study demonstrate that in vitro antitumor immunity is synergistically augmented when FC preparations are accompanied by both ethanol-treated tumor cells and dual TLRs-stimulated DCs through TGF-β1 blockade and IL-12p70 production.